Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/12/12 → 7/31/13 |
Funding
- Merck Sharp & Dohme Corp (MK-3034-043)
MK-3034-043: A Phase 3 Study to Assess Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects with Chronic Hepatitis C Genotype 1
- Alonso, Estella M (PD/PI)
Project: Research project